BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FNC (Azvudine) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of FNC (Azvudine)\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07307586-1026@assetmemo.bio
DTSTAMP:20261121T005631Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:FNC (Azvudine): Phase 3 readout est. (NCT07307586)
DESCRIPTION:FNC (Azvudine)\, phase 3.\nStudy: A Small Sample Prospective Cl
 inical Study of Azvudine Tablets to Promote Clinical Cure in Patients With
  Chronic Hepatitis B\nEstimated primary completion: 31 December 2026. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/azvudine#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT07307586
URL:https://assetmemo.bio/drug/azvudine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
